Superficial Femoral Vein Thrombosis: A Potentially Confusing Term-Reply

JAMA ◽  
1996 ◽  
Vol 275 (6) ◽  
pp. 445
Author(s):  
Warner P. Bundens
Keyword(s):  
Femoral Vein ◽  
Superficial Femoral Vein ◽  
Vein Thrombosis

scholarly journals Effects of intermittent pneumatic compression on femoral vein peak venous velocity during active ankle exercise

2021 ◽  
Vol 29 (1) ◽  
pp. 230949902199810
Author(s):  
Kenta Sakai ◽  
Naonobu Takahira ◽  
Kouji Tsuda ◽  
Akihiko Akamine
Keyword(s):  
Femoral Vein ◽  
Bed Rest ◽  
Intermittent Pneumatic Compression ◽  
Postoperative Rehabilitation ◽  
Venous Flow ◽  
Compression Phase ◽  
Superficial Femoral Vein ◽  
Inpatient Ward ◽  
Vein Thrombosis ◽  
Strong Compression

Introduction: The risk of developing deep vein thrombosis (DVT) is high even after the period of bed rest following major general surgery including total joint arthroplasty (TJA). Mobile intermittent pneumatic compression (IPC) devices allow the application of IPC during postoperative exercise. Although ambulation included ankle movement, no reports have been made regarding the effects of IPC during exercise, including active ankle exercise (AAE), on venous flow. This study was performed to examine whether using a mobile IPC device can effectively augment the AAE-induced increase in peak velocity (PV). Methods: PV was measured by Doppler ultrasonography in the superficial femoral vein at rest, during AAE alone, during IPC alone, and during AAE with IPC in 20 healthy subjects in the sitting position. PV in AAE with IPC was measured with a mobile IPC device during AAE in the strong compression phase. AAE was interrupted from the end of the strong compression phase to minimize lower limb fatigue. Results: AAE with IPC (76.2 cm/s [95%CI, 69.0–83.4]) resulted in a significant increase in PV compared to either AAE or IPC alone (47.1 cm/s [95%CI, 38.7–55.6], p < 0.001 and 48.1 cm/s [95%CI, 43.7–52.4], p < 0.001, respectively). Discussion: Reduced calf muscle pump activity due to the decline in ambulation ability reduced venous flow. Therefore, use of a mobile IPC device during postoperative rehabilitation in hospital and activity including self-training in an inpatient ward may promote venous flow compared to postoperative exercise without IPC. Conclusion: Use of a mobile IPC device significantly increased the PV during AAE, and simultaneous AAE with IPC could be useful evidence for the prevention of DVT in clinical settings, including after TJA.

scholarly journals COMPARISON OF LONG-TERM RESULTS OF FEMORAL VEIN LIGATION AND TRANSCATHETER THROMBOLYSIS IN THROMBOSIS OF THE FEMORAL SEGMENT

2019 ◽  
Vol 178 (5) ◽  
pp. 62-68
Author(s):  
Yu. A. Bezlepkin ◽  
I. N. Sonkin ◽  
A. V. Gusinskiy ◽  
O. V. Fionik ◽  
V. Yu. Melnik ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Pulmonary Thromboembolism ◽  
Femoral Vein ◽  
Detailed Comparison ◽  
Long Term Results ◽  
Superficial Femoral Vein ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Significant Difference ◽  
Deep Vein

INTRODUCTION. The problem of preventing massive pulmonary thromboembolism and post-thrombotic syndrome in deep vein thrombosis has been studied for a long period. The introduction of new treatments for deep vein thrombosis requires a detailed comparison of their effectiveness.The OBJECTIVE of this work was a comparative analysis of ligation of the superficial femoral vein and regional thrombolytic therapy.MATERIAL AND METHODS. A retrospective multicenter study involving 30 patients with femoproplite thrombosis, who had received catheter-directed thrombolysis or ligation of the superficial femoral vein, was performed. The investigated patients underwent inpatient treatment.RESULTS. The data on the effectiveness of both methods in preventing pulmonary thromboembolism were obtained. When comparing both groups, we revealed a statistically significant difference in the frequency of the development of PTS and the severity of its development in 1 year after treatment. With ligation vein, 73.3 and 6.7% in the thrombolysis group (p=0.0005).CONCLUSION. Regional thrombolysis was an effective treatment for deep vein thrombosis and prevention of PTS.The authors declare no conflict of interest.The authors confirm that they respect the rights of the people participated in the study, including obtaining informed consent when it is necessary, and the rules of treatment of animals when they are used in the study. Author Guidelines contains the detailed information.

Challenges in Treating Extensive Deep Vein Thrombosis with Severe Thrombocytopenia in Patients with Antiphospholipid Syndrome—A Follow-up of 2 Years

2019 ◽  
Author(s):  
Lee Kai Wei ◽  
Ashish Anil Sule
Keyword(s):  
Deep Vein Thrombosis ◽  
Antiphospholipid Syndrome ◽  
Lower Limb ◽  
Immune Thrombocytopenia ◽  
Femoral Vein ◽  
Severe Thrombocytopenia ◽  
Bleeding Events ◽  
Superficial Femoral Vein ◽  
Vein Thrombosis ◽  
Deep Vein

AbstractThrombocytopenia is one of the most common manifestations of antiphospholipid syndrome (APS). There is little evidence or definitive guidelines regarding the treatment of APS with thrombocytopenia. We describe a patient with APS and moderate-to-severe thrombocytopenia and the challenges of balancing anticoagulation with thrombocytopenia. A 19-year-old male patient presented with right lower limb swelling to the emergency department with a history of gradually worsening right leg swelling for 1 week and was diagnosed with right leg proximal deep vein thrombosis. Ultrasound Doppler of the right lower limb revealed complete venous thrombosis from the level of the popliteal vein to the distal superficial femoral vein. Subsequently, he was found to have triple-positive APS and moderate-to-severe immune thrombocytopenia, with a platelet count nadir of 31 × 10 to the ninth power/L. He was started on anticoagulation with warfarin. The severe thrombocytopenia was not treated with immunosuppressants and the platelets fluctuated in the range of moderate-to-severe thrombocytopenia but did not develop any rethrombotic or bleeding events. His platelets varied from 31 × 10 to the ninth power/L to 106 × 10 to the ninth power/L. This case report demonstrates that it may be safe to hold off treatment for thrombocytopenia in APS, even in cases of severe thrombocytopenia. Treatment with immunosuppressants may be instituted only when platelet levels fall below 20 × 10 to the ninth power/L or when there is clinically significant bleeding, as in primary immune thrombocytopenia.

scholarly journals Renoportal Anastomosis in Left Lateral Lobe Living Donor Liver Transplantation: A Pediatric Case

2017 ◽  
Vol 11 (3) ◽  
pp. 584-592 ◽  
Author(s):  
Hiroyuki Ogasawara ◽  
Chikashi Nakanishi ◽  
Shigehito Miyagi ◽  
Kazuaki Tokodai ◽  
Yasuyuki Hara ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Femoral Vein ◽  
Lateral Lobe ◽  
Splenorenal Shunt ◽  
Superficial Femoral Vein ◽  
Donor Liver Transplantation ◽  
Vein Thrombosis ◽  
Left Lateral Lobe

In adult liver transplantation, renoportal anastomosis (RPA) has been introduced as a useful technique for patients with grade 4 portal vein thrombosis and a splenorenal shunt. Here, we report a pediatric case in which RPA allowed a left lateral lobe living donor liver transplantation (LDLT) despite portal vein thrombosis and a large splenorenal shunt. At 36 days old, the patient underwent a Kasai operation for biliary atresia. At 17 months old, she underwent LDLT because of repetitive cholangitis. Pretransplant examinations revealed a large splenorenal shunt and portal vein thrombosis. Simple end-to-end portal reconstruction and clamping of the collateral route after removing the thrombosis were unsuccessful. Thus, RPA was performed using a donor superficial femoral vein as an interpositional graft. The portal vein pressure was 20 mm Hg after arterial reperfusion. Ligation of the splenic artery reduced the portal vein pressure. Although she developed severe acute cellular rejection and chylous ascites, there were no signs of portal vein complications. She was discharged 73 days after transplantation without any signs of renal dysfunction. The patient’s condition was good at her last follow-up, 22 months after transplantation. To our knowledge, this is the youngest case of RPA in pediatric left lateral lobe LDLT. Additionally, this is the first case of RPA with splenic artery ligation and using the donor’s superficial femoral vein as the venous graft for RPA. Although long-term follow-up is necessary, RPA could be a salvage option in LDLT in infants if other methods are unsuccessful.

Localized superficial femoral vein thrombosis coupled with iatrogenic arteriovenous fistulas presenting as pulmonary emboli

2011 ◽  
Vol 27 (4) ◽  
pp. 191-193 ◽  
Author(s):  
F De Santis ◽  
M Zywica ◽  
G Mani ◽  
G Martini
Keyword(s):  
Pulmonary Embolism ◽  
Surgical Management ◽  
Femoral Vein ◽  
Rare Condition ◽  
Pulmonary Emboli ◽  
Ivc Filter ◽  
External Compression ◽  
Superficial Femoral Vein ◽  
Arteriovenous Fistulas ◽  
Vein Thrombosis

Introduction ‘Localized’ femoral vein thrombosis (FVT) is a relatively rare condition usually associated with traumas, external compression or iatrogenic etiologies and the consequence can be pulmonary embolism. Report This is the case of a 46-year-old woman who presented with pulmonary emboli secondary to ‘localized’ superficial FVT, coupled with post-puncture arteriovenous fistulas (AVFs), two days after trans-femoral vein radio-frequency cardiac ablation. After placing a temporary IVC-filter, the AVFs were sutured directly while the residual FVT was treated conservatively. Discussion Close local monitoring and adequate medical and surgical management are mandatory to avoid possible dangerous complications, also in apparently ‘low-risk’ iatrogenic AVFs.

Sign in / Sign up

Export Citation Format

Share Document